{"commentary":{"count":93,"free_build_floor":8,"listing_floor":3,"by_channel":{"x_thread":37,"podcast":29,"youtube":27},"note":"Indexed podcasts, YouTube videos and X posts that name this trial. A report screens them, searches for more and cites what clinicians said when it is built."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT04109066\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's public preview; the full report is still bought."},"name":"CheckMate 7FL","nct_id":"NCT04109066","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=checkmate-7fl-nct04109066. The price is fixed at order. We build the report after the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":1950,"size":"deep","size_rule":"Deep: 41+ commentary sources"},"registry":{"acronym":"CheckMate 7FL","arms":[{"description":"Nivolumab with paclitaxel followed by nivolumab with anthracycline + cyclophosphamide as neoadjuvant (pre-surgery) treatment, then nivolumab with adjuvant (post-surgery) endocrine therapy of investigator's choice","label":"Arm A: Nivolumab combined with neoadjuvant CT and adjuvant ET","type":"EXPERIMENTAL"},{"description":"Nivolumab placebo with paclitaxel followed by nivolumab placebo with anthracycline + cyclophosphamide as neoadjuvant (pre-surgery) treatment, then adjuvant (post-surgery) endocrine therapy of investigator's choice","label":"Arm B: Placebo combined with neoadjuvant CT and then adjuvant ET","type":"PLACEBO_COMPARATOR"}],"collaborators":[],"completion_date":{"date":"2023-12-27","type":"ACTUAL"},"conditions":["Breast Cancer"],"enrollment":{"count":521,"type":"ACTUAL"},"has_results":true,"interventions":[{"name":"nivolumab","type":"BIOLOGICAL"},{"name":"paclitaxel (PTX)","type":"DRUG"},{"name":"nivolumab placebo","type":"OTHER"},{"name":"anthracycline","type":"DRUG"},{"name":"cyclophosphamide","type":"DRUG"},{"name":"Endocrine Therapy","type":"DRUG"},{"name":"Surgery","type":"PROCEDURE"}],"last_update":"2025-01-08","lead_sponsor":"Bristol-Myers Squibb","official_title":"A Randomized, Multicenter, Double-blind, Placebo-controlled Phase 3 Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Patients With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer","overall_status":"COMPLETED","phases":["PHASE3"],"primary_completion_date":{"date":"2023-01-16","type":"ACTUAL"},"primary_outcomes":[{"measure":"Pathological Complete Response (pCR) Rate","timeFrame":"Up to approximately 37 months"}],"references":[{"citation":"Loi S, Salgado R, Curigliano G, Romero Diaz RI, Delaloge S, Rojas Garcia CI, Kok M, Saura C, Harbeck N, Mittendorf EA, Yardley DA, Suarez Zaizar A, Caminos FR, Ungureanu A, Reinoso-Toledo JG, Guarneri V, Egle D, Ades F, Pacius M, Chhibber A, Chandra R, Nathani R, Spires T, Wu JQ, Pusztai L, McArthur H. Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trial. Nat Med. 2025 Feb;31(2):433-441. doi: 10.1038/s41591-024-03414-8. Epub 2025 Jan 21.","pmid":"39838118","type":"DERIVED"},{"citation":"Schlam I, Corti C, Sammons S, Mittendorf EA, Tolaney SM. Checkpoint inhibition for early-stage hormone receptor-positive breast cancer. Expert Opin Biol Ther. 2024 Jun;24(6):511-520. doi: 10.1080/14712598.2024.2370395. Epub 2024 Jun 24.","pmid":"38913933","type":"DERIVED"}],"start_date":{"date":"2019-11-18","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer","url":"https://clinicaltrials.gov/study/NCT04109066"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"2.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/checkmate-7fl-nct04109066"}